Preclinical models of infectious diseases
Active Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Eurofins Discovery Services North America, LLC UEI HF4LCAU68M93
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,924,594
Award facts
- Contract value 31% obligated
-
- $1,924,594.00 Current, with exercised options
- $6,166,434.00 Potential, with all options
- Completion date 98% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- St Peters, MO 63304, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $216,610 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | -$207,246 | |
| Original award | $1,915,230 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $6.17M firm fixed-price delivery order to Eurofins Discovery Services North America, LLC for preclinical models of infectious diseases. The delivery order, issued on December 9, 2021, is scheduled for completion by November 30, 2026, and will be performed at the contractor's facility in St. Peters, Missouri. This award falls under the "Nonclinical Services for Development of Interventional Agents" master IDIQ vehicle and does not carry a small business set-aside designation. Eurofins Discovery Services North America is a foreign-owned contract research organization specializing in advanced scientific research and development services, with demonstrated expertise in non-clinical research methodologies including microbiology, analytical chemistry, and toxicology testing.
The contractor brings substantial relevant experience to this engagement, having established itself as a trusted research partner across multiple federal agencies. Eurofins currently holds three significant indefinite delivery vehicles totaling over $34.7M with the FDA, National Institute on Drug Abuse, and Environmental Protection Agency, all emphasizing specialized scientific services and non-clinical research capabilities. The company's prior federal contract portfolio demonstrates particular competency in receptor binding studies, safety pharmacology, in vitro screening, and confirmatory assays—capabilities directly applicable to the development of preclinical infectious disease models. The firm fixed-price structure provides cost certainty for NIAID while leveraging the contractor's established infrastructure and methodological expertise in supporting the agency's infectious disease research initiatives.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Eurofins Discovery Services North America, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 9, 2021.
How much is contract 75N93022F00001 worth?
The government has obligated $1,924,594 on 75N93022F00001. Its potential value, with all options, is $6,166,434.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93018D00007, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award